Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study.

Autor:	Kumar, S K1, Lee, J H2, Lahuerta, J J3, Morgan, G4, Richardson, P G5, Crowley, J6, Haessler, J6, Feather, J5, Hoering, A6, Moreau, P7, LeLeu, X8, Hulin, C9, Klein, S K10, Sonneveld, P10, Siegel, D11, Bladé, J12, Goldschmidt, H13, Jagannath, S14, Miguel, J S15, Orlowski, R16
Zdroj:	Leukemia (08876924). Jan2012, Vol. 26 Issue 1, p149-157. 9p. 4 Charts, 3 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu